Surgery – Means for introducing or removing material from body for...
Reexamination Certificate
2011-08-16
2011-08-16
Chen, Tse (Department: 3777)
Surgery
Means for introducing or removing material from body for...
Reexamination Certificate
active
07998105
ABSTRACT:
A method of treating the intraluminal disease in a coronary artery by injecting therapeutic agents perivascularly into the myocardium near the site of disease.
REFERENCES:
patent: 4146029 (1979-03-01), Ellinwood, Jr.
patent: 4797285 (1989-01-01), Barenholz et al.
patent: 4871549 (1989-10-01), Ueda et al.
patent: 4891223 (1990-01-01), Ambegaonkar et al.
patent: 5190761 (1993-03-01), Liburdy
patent: 5236424 (1993-08-01), Imran
patent: 5246707 (1993-09-01), Haynes
patent: 5275819 (1994-01-01), Amer et al.
patent: 5324325 (1994-06-01), Moaddeb
patent: 5387419 (1995-02-01), Levy et al.
patent: 5439446 (1995-08-01), Barry
patent: 5443495 (1995-08-01), Buscemi et al.
patent: 5510077 (1996-04-01), Dinh et al.
patent: 5527344 (1996-06-01), Arzbaecher et al.
patent: 5551427 (1996-09-01), Altman
patent: 5634895 (1997-06-01), Igo et al.
patent: 5637113 (1997-06-01), Tartaglia et al.
patent: 5662929 (1997-09-01), Lagace et al.
patent: 5681278 (1997-10-01), Igo et al.
patent: 5690682 (1997-11-01), Buscemi et al.
patent: 5700486 (1997-12-01), Canal et al.
patent: 5759573 (1998-06-01), Kim
patent: 5824341 (1998-10-01), Seth et al.
patent: 5843089 (1998-12-01), Sahatjian et al.
patent: 5914345 (1999-06-01), Slepian et al.
patent: 5928669 (1999-07-01), Davis et al.
patent: 5981568 (1999-11-01), Kunz et al.
patent: 6080728 (2000-06-01), Mixson
patent: 6086582 (2000-07-01), Altman et al.
patent: 6087107 (2000-07-01), Sheffield et al.
patent: 6099561 (2000-08-01), Alt
patent: 6110490 (2000-08-01), Thierry
patent: 6152141 (2000-11-01), Stevens et al.
patent: 6156029 (2000-12-01), Mueller
patent: 6199554 (2001-03-01), Mann et al.
patent: 6306125 (2001-10-01), Parker et al.
patent: 6346099 (2002-02-01), Altman
patent: 6379931 (2002-04-01), Rossi et al.
patent: 6709427 (2004-03-01), Nash et al.
patent: 2002/0019350 (2002-02-01), Levine et al.
patent: 2002/0122792 (2002-09-01), Stegmann
patent: 2003/0171294 (2003-09-01), Hung et al.
patent: 2069414 (1990-03-01), None
patent: 7053835 (1995-02-01), None
patent: 7196477 (1995-08-01), None
patent: 9503488 (1997-04-01), None
patent: 10504300 (1998-04-01), None
patent: WO9503036 (1995-02-01), None
patent: PCT/CA96/00725 (1996-10-01), None
Miller et al., Degradation Rates of Oral Resorbable Implants (Polylactates and Polyglycolates): Rate Modification and Changes in PLA/PFA Copolymer Ratios, II J. Biomed. Mater. Res. 711-719 (1977).
Wang et al, pH-Sensitive Immunoliposomes Mediate Target-cell-specific Delivery and Controlled Expression of a Foreign Hene in Mouse, 84 Proc. Nat. Acad. Sci. 7851 (Nov. 1987).
Putney et al., Improving Protein Therapeutics with Sustained-Release Formulations, 16 Nature Biotechnology 153-57 (Feb. 1998).
Kibat et al., Enzymatically Activated Microencapsulated Liposomes Can Provide Pulsatile Drug Release, 4 FASEB Journal 2533 (May 1990).
Chu et al., pH Sensitive Liposomes, 4 Journal of Liposome Rsearch 361-395 (1994).
Liu et al., Role of Cholesterol in the Stability of pH Sensitive, Large Unilamellar Liposomes Prepared by the Detergent-Dialysis Method, 981 Biochem. Biophys. L. Act., 254-60 (1989).
Miller, Lymphatics of the Heart, Raven Press, New York (1982).
Scheinman et al., Supraventricular Tachyarrhythmias: Drug Therapy Versus Catheter Ablation, 17 Clin. Cardiol. II-11 (1994).
Wang et al., Highly Efficient DNA Delivery Mediated by pH-Sensitive Immunoliposomes, 28 Biochemistry 9508 (1989).
Gerasimov, et al., Triggered Release from Liposomes Mediated by Physically and Chemically Induced Phase Transitions, Vesicles, Edited by Morton Rosoff, Marcel Dekker, Inc., New York (1996).
Lazarus et al., Comparative Effects of Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor on Coronary Collateral Development and the Arterial Response to Injury, 94 Circulation 1074-1082 (Sep. 1996).
Lin et al., Expression of recombinant Genes in Myocardium in Vivo After Direct Injection of DNA, 82 Circulation 2217-2221 (Dec. 1990).
French et al., Direct in Vivo Gene Transfer into Porcine Myocardium Using Replication Deficient Adenoviral Vectors, 90 Circulation 2414-2424 (Nov. 1994).
Mulhauser et al., Safety and Efficacy of in Vivo Gene Transfer into the Porcine Heart with Replication-deficient, Recombinant Adenovirus Vectors, 3 Gene Therapy 145-153 (1996).
March et al., Biodegradable Microspheres Containing a Colchicine Analogue Inhibit DNA Synthesis in Vascular Smooth Muscle Cells, 89 Circulation 1929-1933 (May 1994).
Arras et al., The Delivery of Angiogenic Factors to the Heart by Microsphere Therapy, 16 Nature Biotechnology (Feb. 1998).
Biocardia, Inc.
Chen Tse
Cheng Jacqueline
Crockett & Crockett, PC
Crockett, Esq. K. David
LandOfFree
Method of treating coronary arteries with perivascular... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating coronary arteries with perivascular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating coronary arteries with perivascular... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2628326